105 related articles for article (PubMed ID: 10579750)
21. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
22. Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.
Sever PS
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S3-10; discussion S33-4. PubMed ID: 10076915
[TBL] [Abstract][Full Text] [Related]
23. AT1-receptor blockers.
Petkun W
Eur Heart J; 2000 Feb; 21(4):335-7. PubMed ID: 10653684
[No Abstract] [Full Text] [Related]
24. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
[TBL] [Abstract][Full Text] [Related]
25. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
Hagino T; Abe K; Tsunoda K; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765
[TBL] [Abstract][Full Text] [Related]
26. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
[TBL] [Abstract][Full Text] [Related]
27. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S
Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
29. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
30. Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Lin JW; Chang CH; Caffrey JL; Wu LC; Lai MS
Hypertension; 2014 May; 63(5):968-76. PubMed ID: 24516110
[TBL] [Abstract][Full Text] [Related]
31. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
32. [Dosage equivalents of AT1-receptor antagonists available in Germany].
Dominiak P; Häuser W
Dtsch Med Wochenschr; 2003 Oct; 128(44):2315-8. PubMed ID: 14593575
[No Abstract] [Full Text] [Related]
33. [Angiotensin receptor antagonist for therapy of patients with hypertension].
Rakugi H; Ogihara T
Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
[TBL] [Abstract][Full Text] [Related]
34. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM; Goldberg AI
Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
[TBL] [Abstract][Full Text] [Related]
35. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.
Lacourcière Y; Poirier L; Samuel R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1491-501. PubMed ID: 19954310
[TBL] [Abstract][Full Text] [Related]
36. Problems with interpreting the data in Kassler-Taub et al's article comparing irbesartan and losartan.
Bunt T
Am J Hypertens; 1999 Jan; 12(1 Pt 1):79-81. PubMed ID: 10075390
[No Abstract] [Full Text] [Related]
37. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
Gradman AH; Lewin A; Bowling BT; Tonkon M; Deedwania PC; Kezer AE; Hardison JD; Cushing DJ; Michelson EL
Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
[TBL] [Abstract][Full Text] [Related]
39. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
Duprez DA; Weintraub HS; Cushman WC; Purkayastha D; Zappe D; Samuel R; Izzo JL
Blood Press Monit; 2011 Aug; 16(4):186-96. PubMed ID: 21747241
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
Weintraub HS; Duprez DA; Cushman WC; Zappe DH; Purkayastha D; Samuel R; Izzo JL
Cardiovasc Drugs Ther; 2012 Apr; 26(2):145-55. PubMed ID: 22311004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]